These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27132044)

  • 21. Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men.
    Agorastos A; Kellner M; Stiedl O; Muhtz C; Wiedemann K; Demiralay C
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates.
    Fischer AG; Endrass T; Reuter M; Kubisch C; Ullsperger M
    J Neurosci; 2015 May; 35(21):8181-90. PubMed ID: 26019334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype.
    Hinkelmann K; Dragoi L; Gompf J; Muhtz C; Demiralay C; Yassouridis A; Wiedemann K; Kellner M
    Psychiatry Res; 2010 May; 177(3):354-7. PubMed ID: 20381161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans.
    Kosek E; Jensen KB; Lonsdorf TB; Schalling M; Ingvar M
    Mol Pain; 2009 Jul; 5():37. PubMed ID: 19570226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY; Mulsant BH; Ferrell RE; Lotrich FE; Rosen JI; Wallace M; Houck PR; Mazumdar S; Pollock BG
    Int Clin Psychopharmacol; 2010 Jan; 25(1):37-45. PubMed ID: 19996755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.
    Henry ME; Lauriat TL; Lowen SB; Churchill JH; Hodgkinson CA; Goldman D; Renshaw PF
    Psychiatry Res; 2013 Sep; 213(3):217-24. PubMed ID: 23845563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
    Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
    Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
    Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
    Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
    Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
    Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.
    Lenze EJ; Goate AM; Nowotny P; Dixon D; Shi P; Bies RR; Lotrich FK; Rollman BL; Shear MK; Thompson PA; Andreescu C; Pollock BG
    J Clin Psychopharmacol; 2010 Dec; 30(6):672-7. PubMed ID: 21105279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.
    Najjar F; Owley T; Mosconi MW; Jacob S; Hur K; Guter SJ; Sweeney JA; Gibbons RD; Cook EH; Bishop JR
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):467-74. PubMed ID: 26262902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use.
    Lee EJ; Oh MS; Kim JS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Kim HY; Kim J; Seo WK; Lee J; Park SW; Kim YJ; Lee BC;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):271-276. PubMed ID: 29030421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of brain activation during executive functioning in autism with citalopram.
    Wichers RH; Findon JL; Jelsma A; Giampietro V; Stoencheva V; Robertson DM; Murphy CM; McAlonan G; Ecker C; Rubia K; Murphy DGM; Daly EM
    Transl Psychiatry; 2019 Nov; 9(1):286. PubMed ID: 31712584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study.
    Edes AE; McKie S; Szabo E; Kokonyei G; Pap D; Zsombok T; Hullam G; Gonda X; Kozak LR; McFarquhar M; Anderson IM; Deakin JFW; Bagdy G; Juhasz G
    Neuropharmacology; 2020 Jun; 170():107807. PubMed ID: 31593709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
    Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
    World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).
    Brasch-Andersen C; Møller MU; Christiansen L; Thinggaard M; Otto M; Brøsen K; Sindrup SH
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1131-7. PubMed ID: 21614492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.
    Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.